Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Freesmeyer

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Clinical Nuclear Medicine|February 10, 2016
Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine TumorsPhilipp Wilhelm Sänger, Martin Freesmeyer
Nuklearmedizin. Nuclear Medicine|December 15, 2018
Examination of the complexation ability of different calixarene derivatives towards [223Ra]RaCl2 in a hospital radiopharmaceutical laboratoryMartin Freesmeyer, Wolfgang Weigand, Thomas Weisheit
Clinical Nuclear Medicine|March 6, 2015
Radio-guided surgery and postoperative PET/CT scan of a surgical specimen of an intraosseous meningioma in a patient with neuroendocrine tumor of the pancreasMarius Meiser, Thomas Winkens, Martin Freesmeyer
Japanese Journal of Clinical Oncology|August 1, 2014
Detection of a liver metastasis by breath-hold FDG-PET/CT not visible on standard PET/CTRobert Bärwolf, Mariana Zirnsak, Martin Freesmeyer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 7, 2017
Incidental detection of new-onset melanoma using PET-CT in a patient with stage III melanomaSteven Goetze, Martin Freesmeyer, Peter Elsner
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 9, 2016
Breath-hold [68Ga]DOTA-TOC PET/CT in neuroendocrine tumors: detection of additional lesions and effects on quantitative parametersMariana Zirnsak, Robert Bärwolf, Martin Freesmeyer
Radiology|February 13, 2015
ResponseMartin Freesmeyer, Thomas Opfermann, Thomas Winkens
Tomography (Ann Arbor, Mich.)|December 22, 2022
High-Resolution Splenic Imaging: [<sup>68</sup>Ga]Ga-Oxine Red Blood Cell PET/CT for Differentiation of Splenosis Mimicking Malignant LymphomaAnke Werner, Martin Freesmeyer, Robert Drescher
Journal of Medical Imaging and Radiation Oncology|May 19, 2016
Splenic scintigraphy for further differentiation of unclear (68) Ga-DOTATOC-PET/CT findings: Strengths and limitationsChristoph Werner, Thomas Winkens, Martin Freesmeyer
Endocrine|March 9, 2017
Comparing pre-therapeutic <sup>124</sup>I and <sup>131</sup>I uptake tests with intra-therapeutic <sup>131</sup>I uptake in benign thyroid disordersFalk Gühne, Christian Kühnel, Martin Freesmeyer
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Clinical Nuclear Medicine|February 10, 2016
Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine TumorsPhilipp Wilhelm Sänger, Martin Freesmeyer
Nuklearmedizin. Nuclear Medicine|December 15, 2018
Examination of the complexation ability of different calixarene derivatives towards [223Ra]RaCl2 in a hospital radiopharmaceutical laboratoryMartin Freesmeyer, Wolfgang Weigand, Thomas Weisheit
Clinical Nuclear Medicine|March 6, 2015
Radio-guided surgery and postoperative PET/CT scan of a surgical specimen of an intraosseous meningioma in a patient with neuroendocrine tumor of the pancreasMarius Meiser, Thomas Winkens, Martin Freesmeyer
Japanese Journal of Clinical Oncology|August 1, 2014
Detection of a liver metastasis by breath-hold FDG-PET/CT not visible on standard PET/CTRobert Bärwolf, Mariana Zirnsak, Martin Freesmeyer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 7, 2017
Incidental detection of new-onset melanoma using PET-CT in a patient with stage III melanomaSteven Goetze, Martin Freesmeyer, Peter Elsner
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 9, 2016
Breath-hold [68Ga]DOTA-TOC PET/CT in neuroendocrine tumors: detection of additional lesions and effects on quantitative parametersMariana Zirnsak, Robert Bärwolf, Martin Freesmeyer
Radiology|February 13, 2015
ResponseMartin Freesmeyer, Thomas Opfermann, Thomas Winkens
Tomography (Ann Arbor, Mich.)|December 22, 2022
High-Resolution Splenic Imaging: [<sup>68</sup>Ga]Ga-Oxine Red Blood Cell PET/CT for Differentiation of Splenosis Mimicking Malignant LymphomaAnke Werner, Martin Freesmeyer, Robert Drescher
Journal of Medical Imaging and Radiation Oncology|May 19, 2016
Splenic scintigraphy for further differentiation of unclear (68) Ga-DOTATOC-PET/CT findings: Strengths and limitationsChristoph Werner, Thomas Winkens, Martin Freesmeyer
Endocrine|March 9, 2017
Comparing pre-therapeutic <sup>124</sup>I and <sup>131</sup>I uptake tests with intra-therapeutic <sup>131</sup>I uptake in benign thyroid disordersFalk Gühne, Christian Kühnel, Martin Freesmeyer
Pageof 21